DEERFIELD, Ill. / May 29, 2024 / Business Wire / Walgreens today introduced more opportunities for consumers to save throughout the season and beyond.
The company also plans to introduce a series of promotional campaigns, including the return of Walgreens popular myW Days in mid-July.
“Walgreens understands our customers are under financial strain and struggle to purchase everyday essentials. We continue to be committed to our customers by lowering prices on over a thousand additional items, something we’ve been doing since October of 2023,” said Tracey D. Brown, EVP, President, Walgreens Retail & Chief Customer Officer. “Through myWalgreens loyalty program, our more than 110 million members receive personalized offerings daily. Listening to our customers and offering quality products, value, and convenience every day is our continued commitment.”
Walgreens continues to lower prices on more than 1,300 national and store brand products across health and wellness, personal care and seasonal categories.
Examples of price reductions include:
Prices may vary by location, Walgreens.com and the Walgreens app.
About Walgreens
Walgreens (www.walgreens.com) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated healthcare, pharmacy and retail leader. True to its purpose of “more joyful lives through better health,” Walgreens has a more than 120-year heritage of caring for communities and providing trusted pharmacy services, and today is playing a greater role as an independent partner of choice offering healthcare services that improve care, lower costs, and help patients. Operating nearly 9,000 retail locations across the U.S. and Puerto Rico, Walgreens is proud to serve nearly 9 million customers and patients daily. The company’s pharmacists are playing a more critical role in healthcare than ever before, providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for some of the nation’s most underserved populations. Walgreens offers customers and patients a true omnichannel experience, with fully integrated physical and digital platforms designed to deliver high-quality products and healthcare services. Within the U.S. Healthcare segment, Walgreens portfolio also includes businesses in primary care, multi-specialty, post-acute care, urgent care, specialty pharmacy services, population health and provider enablement.
Walgreens News Hub
Walgreens LinkedIn
Walgreens Facebook
| Last Trade: | US$11.56 |
| Daily Change: | -0.02 -0.17 |
| Daily Volume: | 3,770,123 |
| Market Cap: | US$10.010B |
May 20, 2025 March 06, 2025 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
